Menard Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-174
Closed -$90.5K 284
2024
Q4
$90.5K Buy
+174
New +$95.7K 0.05% 154
2024
Q1
Sell
-785
Closed -$417K 109
2023
Q4
$417K Hold
785
0.52% 48
2023
Q3
$397K Buy
785
+44
+6% +$23.4K 0.57% 43
2023
Q2
$387K Sell
741
-14
-2% -$7.55K 0.79% 27
2023
Q1
$435K Buy
755
+14
+2% +$7.89K 1.01% 29
2022
Q4
$408K Hold
741
0.97% 27
2022
Q3
$376K Sell
741
-1,063
-59% -$595K 0.68% 41
2022
Q2
$980K Sell
1,804
-780
-30% -$429K 1.6% 17
2022
Q1
$1.53M Buy
2,584
+122
+5% +$70.1K 1.5% 10
2021
Q4
$1.64M Buy
2,462
+734
+42% +$458K 1.35% 15
2021
Q3
$987K Buy
1,728
+171
+11% +$93.9K 0.87% 21
2021
Q2
$785K Buy
1,557
+74
+5% +$34.9K 0.74% 31
2021
Q1
$677K Sell
1,483
-116
-7% -$55.4K 0.73% 32
2020
Q4
$745K Buy
1,599
+119
+8% +$55.8K 0.8% 30
2020
Q3
$653K Buy
1,480
+107
+8% +$44.2K 0.76% 32
2020
Q2
$497K Buy
+1,373
New +$460K 0.62% 34
2020
Q1
Sell
-2,196
Closed -$713K 110
2019
Q4
$713K Buy
+2,196
New +$666K 0.69% 46

Other funds holding TMO

Menard Financial Group's TMO Position: Q1 2025 in Review

Menard Financial Group sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 174 shares — an estimated $90.5K sold.

Menard Financial Group first reported a position in TMO in Q4 2019 and held it in 17 quarters. The position peaked at $1.64M in Q4 2021. 2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Menard Financial Group reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • Menard Financial Group sold 174 Thermo Fisher Scientific shares in Q1 2025, an estimated $90.5K.
  • Menard Financial Group first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 17 quarters.
  • Menard Financial Group's Thermo Fisher Scientific position peaked at $1.64M in Q4 2021.
  • 2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Menard Financial Group's 13F filing for Q1 2025, filed 8 May 2025.